This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre Hospitalier Universitaire De Nice, National Institute of Health and Medical Research, Université Nice Sophia Antipolis. Active years: 2014.
Company Filing History:
1 out of 5 
1 out of 1,853 
1 out of 18 Years Active: 2014
Title: The Innovations of Thomas Cluzeau
Introduction
Thomas Cluzeau is a notable inventor based in Nice, France. He has made significant contributions to the field of medical treatment, particularly in addressing myeloid neoplasias. His innovative approach has led to the development of a unique method that utilizes specific compounds for therapeutic purposes.
Latest Patents
Cluzeau holds a patent for a method of treating human patients suffering from myeloid neoplasias using 5-aminoimidazole-4-carboxamide. This method involves administering a therapeutically effective amount of acadesine, its precursors, or derivatives to patients. This patent highlights his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Throughout his career, Thomas Cluzeau has worked with esteemed institutions such as Université Nice Sophia Antipolis and Centre Hospitalier Universitaire de Nice. His work in these organizations has allowed him to collaborate with other professionals and contribute to significant advancements in medical research.
Collaborations
Cluzeau has collaborated with notable colleagues, including Patrick Auberger and Guillaume Robert. These partnerships have fostered an environment of innovation and have been instrumental in the development of his patented methods.
Conclusion
Thomas Cluzeau's contributions to the field of medical treatment through his innovative patent demonstrate his dedication to improving healthcare. His work continues to inspire advancements in the treatment of myeloid neoplasias.